Actively Recruiting
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Led by The Lymphoma Academic Research Organisation · Updated on 2026-01-14
150
Participants Needed
31
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP). This registry is opened in France and in Belgium
CONDITIONS
Official Title
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with an anaplastic large cell lymphoma associated with breast implants
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 31 locations
1
A. Z. Sint-Jan Brugge-Oostende AV
Bruges, Belgium
Actively Recruiting
2
Clinique Universitaire Saint LUC
Brussels, Belgium
Actively Recruiting
3
Cliniques Universitaires de Bruxelles - Hôpital Erasme
Brussels, Belgium
Not Yet Recruiting
4
Institut Jules Bordet
Brussels, Belgium
Actively Recruiting
5
Universitair Ziekenhuis Brussel
Brussels, Belgium
Not Yet Recruiting
6
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Not Yet Recruiting
7
Universitair Ziekenhuis Gent
Ghent, Belgium
Actively Recruiting
8
U.Z. Leuven - Campus Gasthuisberg
Leuven, Belgium
Actively Recruiting
9
CHU de Liège -Domaine Sart Tilman
Liège, Belgium
Actively Recruiting
10
CHU UCL Namur - Site Godinne
Yvoir, Belgium
Actively Recruiting
11
CH d Avignon - Hopital Henri Duffaut
Avignon, France
Actively Recruiting
12
Institut Bergonié
Bordeaux, France
Actively Recruiting
13
CHRU de Brest - Hôpital Morvan
Brest, France
Actively Recruiting
14
Hopital Louis Pasteur
Colmar, France
Actively Recruiting
15
APHP - Hopital Henri Mondor
Créteil, France
Actively Recruiting
16
CHU de Dijon - Hôpital le Bocage
Dijon, France, 21034
Actively Recruiting
17
Centre Médical la Roseraie
Lille, France
Actively Recruiting
18
Centre Léon Bérard
Lyon, France
Actively Recruiting
19
Institut Paoli Calmettes
Marseille, France
Actively Recruiting
20
CH Saint-Eloi
Montpellier, France
Actively Recruiting
21
CHU de Nantes - Hôtel Dieu
Nantes, France
Actively Recruiting
22
Hôpital Cochin
Paris, France
Actively Recruiting
23
CH de Pau
Pau, France
Actively Recruiting
24
CH de Perpigan
Perpignan, France
Actively Recruiting
25
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Actively Recruiting
26
Chu de Reims - Hopital Robert Debre
Reims, France
Actively Recruiting
27
Centre Henri Becquerel
Rouen, France
Actively Recruiting
28
Centre Rene Hugenin
Saint-Cloud, France, 92210
Actively Recruiting
29
CH de Saint Malo
St-Malo, France
Actively Recruiting
30
CHRU de Strasbourg
Strasbourg, France, 67100
Actively Recruiting
31
Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O)
Toulouse, France
Actively Recruiting
Research Team
M
Manon Croix
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here